5 search results for vulvovaginal atrophy

Changes in the Vagina and Vulva, Sexual Side Effects of Menopause | The North American Menopause Society, NAMS

https://www.menopause.org/for-women/sexual-health-menopause-online/changes-at-midlife/changes-in-the-vagina-and-vulva

. Both the vagina and the external female genitals (vulva) are affected. Vulvovaginal atrophy. During, thinner, drier, and less elastic or flexible—a condition known as "vulvovaginal atrophy" (see, makes it less flexible. Dry, fragile vulvovaginal tissues are susceptible to injury, tearing, . That’s because dry, fragile vulvovaginal tissues are susceptible to injury, tearing, and bleeding, , as discussed later. These menopause-related vulvovaginal symptoms may occur early in the menopause

The ABCs of SERMs

of menopause, also known as vulvovaginal atrophy, which can lead to painful sex. And although

Not Time to Abandon Use of Local Vaginal Hormone Therapies

https://www.menopause.org/for-professionals/not-time-to-abandon-use-of-local-vaginal-hormone-therapies

of menopause (GSM), previously referred to as vulvovaginal atrophy, a progressive condition, vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013;20(9, vulvovaginal symptoms should choose the cheapest moisturizer or lubricant available over-the-counter, vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial [published, the approach to managing postmenopausal vulvovaginal symptoms [published online ahead of print March 19, 2018

-em-Menopause Care Updates-em-

https://www.menopause.org/publications/professional-publications/-em-menopause-care-updates-em-

local agent for treatment of vulvovaginal atrophy symptoms De Seta F, Caruso S, Di Lorenzo G, associated with vulvovaginal atrophy in postmenopausal women: a double-blind randomized placebo, overactive bladder symptoms in women with vulvovaginal atrophy Schiavi MC, Zullo MA, Faiano P, et al. Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12, . September 2020 Expanding pharmacologic options for women with vaginal atrophy and detrusor

-em-Menopause e-Consult-em-

https://www.menopause.org/publications/professional-publications/-em-menopause-e-consult-em-

woman presents to you with moderate to severe hot flashes, vaginal atrophy, sleep disturbances, symptoms included vulvovaginal itching, discomfort with urination, and dyspareunia. She has lived, except for mild vaginal atrophy, and laboratory tests show a high follicle-stimulating hormone level